 From this research, synthetic endeavours lead to the development of montelukast and zafirlukast as cysteinyl-leukotriene type 1 receptor antagonists.Quinolines were shown to be good moiety for CysLT1 receptor antagonist.From weak antagonistic derivatives of quinolines, montelukast was developed.